Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | MOR210 |
Trade Name | |
Synonyms | TJ210|MPR 210|MOR-210|TJ 210|TJ-210|TJ210001|WBP2191 |
Drug Descriptions |
MOR210 (TJ210) is a human antibody against complement component fragment 5a receptor (C5aR1, CD88), which may block C5aR1 signaling and induce anti-tumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C177110 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MOR210 | MOR210 | 0 | 1 |